Literature DB >> 16446410

Psychopharmacology and memory.

W Glannon1.   

Abstract

Psychotropic and other drugs can alter brain mechanisms regulating the formation, storage, and retrieval of different types of memory. These include "off label" uses of existing drugs and new drugs designed specifically to target the neural bases of memory. This paper discusses the use of beta-adrenergic antagonists to prevent or erase non-conscious pathological emotional memories in the amygdala. It also discusses the use of novel psychopharmacological agents to enhance long term semantic and short term working memory by altering storage and retrieval mechanisms in the hippocampus and prefrontal cortex. Although intervention in the brain to alter memory as therapy or enhancement holds considerable promise, the long term effects of experimental drugs on the brain and memory are not known. More studies are needed to adequately assess the potential benefits and risks of these interventions.

Mesh:

Substances:

Year:  2006        PMID: 16446410      PMCID: PMC2563336          DOI: 10.1136/jme.2005.012575

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  12 in total

Review 1.  Emerging ethical issues in neuroscience.

Authors:  Martha J Farah
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

Review 2.  Memory enhancement: the search for mechanism-based drugs.

Authors:  Gary Lynch
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

3.  Neurobiological basis of psychopathy.

Authors:  R James R Blair
Journal:  Br J Psychiatry       Date:  2003-01       Impact factor: 9.319

4.  Medicine. What are the right targets for psychopharmacology?

Authors:  Steven E Hyman; Wayne S Fenton
Journal:  Science       Date:  2003-01-17       Impact factor: 47.728

5.  Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.

Authors:  Charles W Hoge; Carl A Castro; Stephen C Messer; Dennis McGurk; Dave I Cotting; Robert L Koffman
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

Review 6.  Neurocognitive enhancement: what can we do and what should we do?

Authors:  Martha J Farah; Judy Illes; Robert Cook-Deegan; Howard Gardner; Eric Kandel; Patricia King; Eric Parens; Barbara Sahakian; Paul Root Wolpe
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

7.  Human aggression.

Authors:  Craig A Anderson; Brad J Bushman
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

8.  Pilot study of secondary prevention of posttraumatic stress disorder with propranolol.

Authors:  Roger K Pitman; Kathy M Sanders; Randall M Zusman; Anna R Healy; Farah Cheema; Natasha B Lasko; Larry Cahill; Scott P Orr
Journal:  Biol Psychiatry       Date:  2002-01-15       Impact factor: 13.382

Review 9.  Targeting the CREB pathway for memory enhancers.

Authors:  Tim Tully; Rusiko Bourtchouladze; Rod Scott; John Tallman
Journal:  Nat Rev Drug Discov       Date:  2003-04       Impact factor: 84.694

10.  An emotion-induced retrograde amnesia in humans is amygdala- and beta-adrenergic-dependent.

Authors:  B A Strange; R Hurlemann; R J Dolan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more
  9 in total

1.  Psychopharmacology of memory.

Authors:  H Valerie Curran; Miriam Z Mintzer
Journal:  Psychopharmacology (Berl)       Date:  2006-11       Impact factor: 4.530

2.  Exposure to a fearful context during periods of memory plasticity impairs extinction via hyperactivation of frontal-amygdalar circuits.

Authors:  James M Stafford; DeeAnna K Maughan; Elena C Ilioi; K Matthew Lattal
Journal:  Learn Mem       Date:  2013-02-19       Impact factor: 2.460

Review 3.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

4.  Psychophysiological responding to emotional memories in healthy young men after cortisol and propranolol administration.

Authors:  Marieke S Tollenaar; Bernet M Elzinga; Philip Spinhoven; Walter Everaerd
Journal:  Psychopharmacology (Berl)       Date:  2009-01-13       Impact factor: 4.530

5.  Regulation of excitatory synapses and fearful memories by stress hormones.

Authors:  Harm J Krugers; Ming Zhou; Marian Joëls; Merel Kindt
Journal:  Front Behav Neurosci       Date:  2011-10-11       Impact factor: 3.558

6.  Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions.

Authors:  Tina Tomažič; Anita Kovačič Čelofiga
Journal:  Philos Ethics Humanit Med       Date:  2019-04-25       Impact factor: 2.464

7.  Factors Associated with Variability in Pulse Wave Transit Time Using Pulse Oximetry: A Retrospective Study.

Authors:  Hilmanda Budiman; Ryo Wakita; Takaya Ito; Shigeru Maeda
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

Review 8.  If I could just stop loving you: anti-love biotechnology and the ethics of a chemical breakup.

Authors:  Brian D Earp; Olga A Wudarczyk; Anders Sandberg; Julian Savulescu
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

9.  Enhancement for well-being is still ethically challenging.

Authors:  Saskia K Nagel
Journal:  Front Syst Neurosci       Date:  2014-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.